Macroaxis considers Bharat Immunologicals to be not very risky. Bharat Immunologicals secures Sharpe Ratio (or Efficiency) of -0.3108 which signifies that Bharat Immunologicals had -0.3108% of return per unit of standard deviation over the last 1 month. Macroaxis philosophy in foreseeing risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Bharat Immunologicals Biologicals Corp Ltd exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Bharat Immunologicals Mean Deviation of 0.406 and Risk Adjusted Performance of 0.01 to double-check risk estimate we provide.
|Time Horizon||30 Days Login to change|
Bharat Immunologicals Technical Analysis
Projected Return Density Against MarketAssuming 30 trading days horizon, Bharat Immunologicals has beta of 0.0 . This suggests unless we do not have required data, the returns on DOW and Bharat Immunologicals are completely uncorrelated. Furthermore, Bharat Immunologicals Biologicals Corp LtdIt does not look like Bharat Immunologicals alpha can have any bearing on the equity current valuation.
Predicted Return Density